Kish SJ - Search Results

1

Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.

Kish SJ, Tong J, Hornykiewicz O, Rajput A, Chang LJ, Guttman M, Furukawa Y. Kish SJ, et al. Brain. 2008 Jan;131(Pt 1):120-31. doi: 10.1093/brain/awm239. Epub 2007 Oct 22. Brain. 2008. PMID: 17956909

2

Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline.

Tong J, Hornykiewicz O, Kish SJ. Tong J, et al. Among authors: kish sj. Arch Neurol. 2006 Dec;63(12):1724-8. doi: 10.1001/archneur.63.12.1724. Arch Neurol. 2006. PMID: 17172611

3

Marked dissociation between high noradrenaline versus low noradrenaline transporter levels in human nucleus accumbens.

Tong J, Hornykiewicz O, Furukawa Y, Kish SJ. Tong J, et al. Among authors: kish sj. J Neurochem. 2007 Sep;102(5):1691-1702. doi: 10.1111/j.1471-4159.2007.04636.x. Epub 2007 May 4. J Neurochem. 2007. PMID: 17484728 Free article.

4

Brain serotonin transporter in human methamphetamine users.

Kish SJ, Fitzmaurice PS, Boileau I, Schmunk GA, Ang LC, Furukawa Y, Chang LJ, Wickham DJ, Sherwin A, Tong J. Kish SJ, et al. Psychopharmacology (Berl). 2009 Mar;202(4):649-61. doi: 10.1007/s00213-008-1346-x. Epub 2008 Oct 8. Psychopharmacology (Berl). 2009. PMID: 18841348

5

Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.

Boileau I, Guttman M, Rusjan P, Adams JR, Houle S, Tong J, Hornykiewicz O, Furukawa Y, Wilson AA, Kapur S, Kish SJ. Boileau I, et al. Among authors: kish sj. Brain. 2009 May;132(Pt 5):1366-75. doi: 10.1093/brain/awn337. Epub 2009 Jan 19. Brain. 2009. PMID: 19153147

6

Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.

Kish SJ, Lerch J, Furukawa Y, Tong J, McCluskey T, Wilkins D, Houle S, Meyer J, Mundo E, Wilson AA, Rusjan PM, Saint-Cyr JA, Guttman M, Collins DL, Shapiro C, Warsh JJ, Boileau I. Kish SJ, et al. Brain. 2010 Jun;133(Pt 6):1779-97. doi: 10.1093/brain/awq103. Epub 2010 May 17. Brain. 2010. PMID: 20483717 Free PMC article.

7

Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.

Tong J, Ang LC, Williams B, Furukawa Y, Fitzmaurice P, Guttman M, Boileau I, Hornykiewicz O, Kish SJ. Tong J, et al. Among authors: kish sj. Neurobiol Dis. 2015 Oct;82:243-253. doi: 10.1016/j.nbd.2015.06.010. Epub 2015 Jun 21. Neurobiol Dis. 2015. PMID: 26102022 Free PMC article.

8

D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia.

Payer DE, Guttman M, Kish SJ, Tong J, Adams JR, Rusjan P, Houle S, Furukawa Y, Wilson AA, Boileau I. Payer DE, et al. Among authors: kish sj. Neurology. 2016 Jan 19;86(3):224-30. doi: 10.1212/WNL.0000000000002285. Epub 2015 Dec 30. Neurology. 2016. PMID: 26718579 Free PMC article.

9

A marked contrast between serotonergic and dopaminergic changes in dopa-responsive dystonia.

Furukawa Y, Rajput AH, Tong J, Tomizawa Y, Hornykiewicz O, Kish SJ. Furukawa Y, et al. Among authors: kish sj. Neurology. 2016 Sep 6;87(10):1060-1. doi: 10.1212/WNL.0000000000003065. Epub 2016 Aug 3. Neurology. 2016. PMID: 27488599 Free PMC article. No abstract available.

10

Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.

Tong J, Rathitharan G, Meyer JH, Furukawa Y, Ang LC, Boileau I, Guttman M, Hornykiewicz O, Kish SJ. Tong J, et al. Among authors: kish sj. Brain. 2017 Sep 1;140(9):2460-2474. doi: 10.1093/brain/awx172. Brain. 2017. PMID: 29050386 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters